Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Rev. esp. anestesiol. reanim ; 63(1): 29-47, ene. 2016. tab, ilus
Article in Spanish | IBECS | ID: ibc-150074

ABSTRACT

Esta Guía de Práctica Clínica responde a preguntas clínicas sobre seguridad en la elección de fluido (cristaloide, coloide o Hidroxietilalmidón 130) en pacientes que precisan restauración volémica en el periodo perioperatorio de cirugía no cardiaca. A partir del resumen de la evidencia, se elaboraron las recomendaciones siguiendo la metodología GRADE. En esta población se sugiere la fluidoterapia basada en la administración de cristaloides, (recomendación débil, calidad de la evidencia baja). En las situaciones en las que la restauración volémica no se alcance sólo con cristaloides, se sugiere utilizar coloides sintéticos (Hidroxietilalmidón 130 o gelatina fluida modificada) en lugar de Albúmina 5% (recomendación débil, calidad de la evidencia baja). La elección y dosificación de coloide deberán basarse en las características del producto, comorbilidad del paciente y experiencia del anestesiólogo (AU)


The present Clinical practice guide responds to the clinical questions about security in the choice of fluid (crystalloid, colloid or hydroxyethyl starch 130) in patients who require volume replacement during perioperative period of non-cardiac surgeries. From the evidence summary, recommendations were made following the GRADE methodology. In this population fluid therapy based on crystalloids is suggested (weak recommendation, low quality evidence). In the events where volume replacement is not reached with crystalloids, the use of synthetic colloids (hydroxyethyl starch 130 or modified fluid gelatin) is suggested instead of 5% albumin (weak recommendation, low quality evidence). The choice and dosage of the colloid should be based in the product characteristics, patient comorbidity and anesthesiologist's experience (AU)


Subject(s)
Humans , Male , Female , Thoracic Surgery/methods , Colloids/administration & dosage , Fluid Therapy/methods , Pharmaceutical Preparations/administration & dosage , Communicable Diseases/pathology , Communicable Diseases/transmission , Anesthetics, Intravenous/administration & dosage , Anesthetics, Intravenous/metabolism , Polygeline/metabolism , Spain/ethnology , Thoracic Surgery/standards , Colloids/metabolism , Fluid Therapy , Pharmaceutical Preparations/metabolism , Communicable Diseases/genetics , Communicable Diseases/metabolism , Anesthetics, Intravenous/supply & distribution , Anesthetics, Intravenous/toxicity , Polygeline
2.
Rev. esp. anestesiol. reanim ; 61(5): 281-283, mayo 2014.
Article in Spanish | IBECS | ID: ibc-121226

ABSTRACT

La tetralogía de Fallot es una cardiopatía congénita que representa el 11-13% de estas. La estenosis e hipoplasia de las arterias pulmonares aparecen en un alto porcentaje, debido a que esta enfermedad cursa con una estenosis nativa de la rama pulmonar y a que la cirugía previa la puede estenosar. Los stents intravasculares expandibles mediante balón son una técnica alternativa a la reintervención en pacientes con cardiopatías congénitas. Sin embargo, a pesar del progresivo incremento de su utilización, el limitado número de procedimientos asociado a la amplia variedad anatómica y diferentes características de estos pacientes hace que aun en manos expertas, la implantación de stents en estos pacientes asocie una incidencia no despreciable de complicaciones, las cuales no son siempre inocuas y obligan en ocasiones a realizar tratamientos quirúrgicos en enfermos ya multiintervenidos, lo que aumenta la complejidad y el riesgo (AU)


Tetralogy of Fallot is a congenital heart disease that accounts for 11-13% of the congenital cardiomyopathies. Stenosis and hyperplasia of the pulmonary arteries occur in a high proportion of them as this disease causes a native stenosis of the pulmonary branch, which can be surgically repaired with a stent. The use of balloon expandable intravascular stents is an alternative technique to further surgery in patients with congenital heart diseases. However, despite the gradual increase in their use, the limited number of procedures, combined with the wide anatomical variability and different characteristics of these patients, even in expert hands, stent implants are associated with a not inconsiderable incidence of complications. These are not always obvious and often require performing surgery in patients who have already had multiple interventions, thus increasing the complexity and the risk (AU)


Subject(s)
Humans , Male , Tetralogy of Fallot/surgery , Tetralogy of Fallot , Stents , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/drug therapy , Heart Defects, Congenital/surgery , Pulmonary Valve Stenosis/complications , Tetralogy of Fallot/drug therapy , Stents/adverse effects , Stents , Aortic Valve Stenosis/complications , Pulmonary Valve Stenosis/chemically induced , Pulmonary Valve Stenosis/surgery , Pulmonary Valve Stenosis
SELECTION OF CITATIONS
SEARCH DETAIL
...